content-validator
2
总安装量
1
周安装量
#74011
全站排名
安装命令
npx skills add https://github.com/u9401066/copilot-capability-manager --skill content-validator
Agent 安装分布
openclaw
1
opencode
1
cursor
1
claude-code
1
gemini-cli
1
Skill 文档
å §å®¹é©èæè½ (Content Validator)
æè¿°
é©èæ°å¯«å §å®¹æ¯å¦å¿ å¯¦åæ ä¾æºææï¼ç¢ºä¿å¼ç¨æºç¢ºãäºå¯¦æ£ç¢ºã
è§¸ç¼æ¢ä»¶
- ãé©èå §å®¹ããæª¢æ¥æºç¢ºæ§ããæ ¸å°å¼ç¨ã
- “validate”, “verify”, “fact check”, “check accuracy”
- 宿çè¨æå ±åå¾éè¦å質檢æ¥
Agent é©èè½å
1. 便ºæ¯å°
Agent æå°æ°å¯«å §å®¹èåå§ä¾æºéé æ¯å°ï¼
# é©èæµç¨å½ä»£ç¢¼
def validate_content(note: str, source: str) -> ValidationResult:
results = []
# 1. æåçè¨ä¸çææäºå¯¦é³è¿°
claims = extract_claims(note)
# 2. å°æ¯åé³è¿°å¨ä¾æºä¸å°æ¾æ¯æ
for claim in claims:
support = find_support_in_source(claim, source)
if support.found:
results.append({"claim": claim, "status": "â
å·²é©è", "source": support.location})
elif support.partial:
results.append({"claim": claim, "status": "â ï¸ é¨åæ¯æ", "note": support.note})
else:
results.append({"claim": claim, "status": "â æªæ¾å°æ¯æ", "action": "éè¦ä¿®æ£æè£å
å¼ç¨"})
return results
2. æ¸ææºç¢ºæ§æª¢æ¥
| 檢æ¥é ç® | é©èæ¹å¼ |
|---|---|
| æ¸åå¼ç¨ | æ¯å°ä¾æºä¸çæ¸å¼ |
| çµ±è¨çµæ | ç¢ºèª p å¼ãCIãOR ç |
| ç¾åæ¯ | éæ°è¨ç®é©è |
| æ¥æ/年份 | è便ºäº¤åæ ¸å° |
3. å¼ç¨æ ¼å¼æª¢æ¥
def check_citations(note: str, references: list) -> list:
issues = []
# æ¾åºææå¼ç¨æ¨è¨
citations = find_citation_markers(note)
for cite in citations:
# 檢æ¥å¼ç¨æ¯å¦å卿¼åèæç»
if cite not in references:
issues.append(f"å¼ç¨ {cite} ä¸å¨åèæç»ä¸")
# 檢æ¥å¼ç¨æ ¼å¼æ¯å¦æ£ç¢º
if not is_valid_format(cite):
issues.append(f"å¼ç¨ {cite} æ ¼å¼ä¸æ£ç¢º")
return issues
å·è¡æµç¨
宿´é©èæµç¨
輸å
¥ï¼çè¨/å ±å + åå§ä¾æº
â
Step 1: äºå¯¦é³è¿°æå
- è奿æå¯é©èçé³è¿°
â
Step 2: 便ºæ¯å°
- é䏿¯å°ä¾æºæ¯æåº¦
â
Step 3: æ¸æé©è
- æª¢æ¥æææ¸ååçµ±è¨
â
Step 4: å¼ç¨æª¢æ¥
- é©èå¼ç¨æ ¼å¼åå卿§
â
Step 5: ä¸è´æ§æª¢æ¥
- 檢æ¥å
§é¨é輯ä¸è´æ§
â
輸åºï¼é©èå ±å + ä¿®æ£å»ºè°
è¼¸åºæ ¼å¼
## å
§å®¹é©èå ±å
**é©èæé**: 2024-12-22 10:30
**便ºæä»¶**: smith-2024-remimazolam.pdf
**é©èå°è±¡**: notes/smith-2024-summary.md
---
### ð é©èæè¦
| é¡å¥ | éé | è¦å | é¯èª¤ |
|------|------|------|------|
| äºå¯¦é³è¿° | 12 | 2 | 1 |
| æ¸æå¼ç¨ | 8 | 1 | 0 |
| å¼ç¨æ ¼å¼ | 5 | 0 | 0 |
| **總è¨** | **25** | **3** | **1** |
**é©èçµæ**: â ï¸ éè¦ä¿®æ£
---
### â
å·²é©èé
ç®
| é³è¿° | 便ºä½ç½® |
|------|----------|
| "Remimazolam èµ·ææé 1-2 åé" | p.3, Methods |
| "ç´å
¥ 15 ç¯ RCT" | p.2, Abstract |
| ... | ... |
### â ï¸ éè¦ç¢ºèª
| é³è¿° | åé¡ | å»ºè° |
|------|------|------|
| "ä½è¡å£ç¼ççéä½ 22%" | 便ºå¯« "relative risk 0.78" | ä¿®æ£çº RR æè¨ç®æ£ç¢ºç¾åæ¯ |
| "2,340 ä½ç
æ£" | 便ºå¯« "2,334 participants" | æ´æ£æ¸å |
### â é¯èª¤é
ç®
| é³è¿° | åé¡ | ä¿®æ£å»ºè° |
|------|------|----------|
| "ç ç©¶çµè«æ¨è¦é¦é¸ä½¿ç¨" | 便ºæªææ¤çµè« | åªé¤ææ¹çº "ä½è
建è°å¯èæ
®ä½¿ç¨" |
---
### ð ä¿®æ£æ¸
å®
1. [ ] 第 23 è¡ï¼å° "22%" æ¹çº "RR 0.78 (22% ç¸å°é¢¨éªéä½)"
2. [ ] 第 31 è¡ï¼å° "2,340" æ¹çº "2,334"
3. [ ] 第 45 è¡ï¼åªé¤ "é¦é¸ä½¿ç¨" æ¹çº "å¯èæ
®ä½¿ç¨"
---
### âï¸ èªåä¿®æ£ (å¯é¸)
å¦éèªåä¿®æ£å·²æ¨è¨çé¯èª¤ï¼è«ç¢ºèªå¾å·è¡ã
使ç¨ç¯ä¾
ç¯ä¾ 1ï¼å¿«éé©è
ç¨æ¶ï¼ãé©èé份çè¨çæºç¢ºæ§ã
å·è¡ï¼
1. è®åçè¨ååå§ä¾æº
2. æåå¯é©èé³è¿°
3. æ¯å°é©è
4. ç¢åºé©èå ±å
ç¯ä¾ 2ï¼æ¸æé©è
ç¨æ¶ï¼ã檢æ¥å ±åä¸çææçµ±è¨æ¸æã
å·è¡ï¼
1. æ¾åºæææ¸ååçµ±è¨å¼
2. è便ºæ¯å°
3. æ¨è¨ä¸ä¸è´é
ç®
ç¯ä¾ 3ï¼å¼ç¨æª¢æ¥
ç¨æ¶ï¼ãç¢ºèªææå¼ç¨é½æ£ç¢ºã
å·è¡ï¼
1. æåææå¼ç¨æ¨è¨
2. æ¯å°åèæç»æ¸
å®
3. 檢æ¥å¼ç¨æ ¼å¼
é©èå´æ ¼åº¦
| çç´ | 說æ | é©ç¨å ´æ¯ |
|---|---|---|
| Strict | æ¯åæ¸åé½å¿ é å®å ¨ä¸è´ | ç¼è¡¨è«æãæ£å¼å ±å |
| Normal | å è¨±åæ¨äºå ¥å·®ç° | ä¸è¬çè¨ãå §é¨æä»¶ |
| Lenient | åªæª¢æ¥é大é¯èª¤ | å¿«éç覽ãå稿 |
ç¸éæè½
note-writer– æ°å¯«çè¨report-formatter– æ ¼å¼åå ±åreport-writing– çµåæè½ï¼å®æ´å ±åæ°å¯«